IDH Mutation Analysis in Gliomas as a Diagnostic and Prognostic Biomarker

被引：0
|
作者：
Kurian, K. [1 ]
Haynes, H. [1 ]
Crosby, C. [2 ]
Hopkins, K. [3 ]
Williams, M. [2 ]
机构：
[1] Frenchay Hosp, Dept Neuropathol, Bristol BS16 1LE, Avon, England
[2] Southmead Hosp, Bristol Genet Lab, Bristol, Avon, England
[3] Bristol Neurooncol Ctr, Bristol, Avon, England
来源：
JOURNAL OF PATHOLOGY | 2013年 / 229卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [41] PROGNOSTIC VALUE OF CONTRAST ENHANCEMENT AND HISTOPATHOLOGICAL GRADING IN DIFFUSE GLIOMAS DEPENDS ON IDH1/2 MUTATION
    Suchorska, B.
    Biczok, A.
    Lenski, M.
    Albert, N. L.
    Schueller, U.
    Tonn, J.
    NEURO-ONCOLOGY, 2016, 18 : 37 - 37
  • [42] Validation of Immunohistochemistry for Identification of IDH1 Mutation in Gliomas
    Egoavil, C. M.
    Paya, A.
    Irles, E.
    Garcia-Martinez, A.
    Soto, J. L.
    Castillejo, A.
    Castillejo, M. I.
    Quintanar, T.
    Herrero, J.
    Rodriguez-Lescure, A.
    Portugues, M. J.
    Moreno, P.
    Heredia, L.
    Andrada, E.
    Aranda, I.
    Barbera, V. M.
    Alenda, C.
    LABORATORY INVESTIGATION, 2013, 93 : 474A - 474A
  • [43] Malignant clinical features of anaplastic gliomas without IDH mutation
    Shibahara, Ichiyo
    Sonoda, Yukihiko
    Shoji, Takuhiro
    Kanamori, Masayuki
    Saito, Ryuta
    Inoue, Tomoo
    Kawaguchi, Tomohiro
    Yamashita, Yoji
    Watanabe, Takashi
    Kumabe, Toshihiro
    Watanabe, Mika
    Suzuki, Hiroyoshi
    Tominaga, Teiji
    NEURO-ONCOLOGY, 2015, 17 (01) : 136 - 144
  • [44] Comprehensive mRNA Prognostic Biomarker Analysis of Grade 2/3 Gliomas
    Beyer, S.
    Bell, E. H.
    McElroy, J.
    Oehlke, O.
    Fleming, J.
    Becker, A.
    Staszewski, O.
    Prinz, M.
    Grosu, A.
    Chakravarti, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E578 - E578
  • [45] DIFFUSION KURTOSIS IMAGING IDENTIFIES THE IDH MUTATION STATUS OF GLIOMAS
    Abdalla, Gehad
    Mancini, Laura
    Sanverdi, S. Eser
    Yousry, Tarek
    Bisdas, Sotirios
    NEURO-ONCOLOGY, 2018, 20 : 351 - 351
  • [46] Validation of Immunohistochemistry for Identification of IDH1 Mutation in Gliomas
    Egoavil, C. M.
    Paya, A.
    Irles, E.
    Garcia-Martinez, A.
    Soto, J. L.
    Castillejo, A.
    Castillejo, M. I.
    Quintanar, T.
    Herrero, J.
    Rodriguez-Lescure, A.
    Portugues, M. J.
    Moreno, P.
    Heredia, L.
    Andrada, E.
    Aranda, I.
    Barbera, V. M.
    Alenda, C.
    MODERN PATHOLOGY, 2013, 26 : 474A - 474A
  • [47] Pharmacoresistant seizures and IDH mutation in low-grade gliomas
    Correia, Carlos Eduardo
    Umemura, Yoshie
    Flynn, Jessica R.
    Reiner, Anne S.
    Avila, Edward K.
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [48] PROGNOSTIC STRATIFICATION OF IDH WILD TYPE LOWER GRADE GLIOMAS
    Ng, Ho Keung
    NEURO-ONCOLOGY, 2018, 20 : 2 - 2
  • [49] Accuracy of Radiomics in Predicting IDH Mutation Status in Diffuse Gliomas: A Bivariate Meta-Analysis
    Di Salle, Gianfranco
    Tumminello, Lorenzo
    Laino, Maria Elena
    Shalaby, Sherif
    Aghakhanyan, Gayane
    Fanni, Salvatore Claudio
    Febi, Maria
    Shortrede, Jorge Eduardo
    Miccoli, Mario
    Faggioni, Lorenzo
    Cosottini, Mirco
    Neri, Emanuele
    RADIOLOGY-ARTIFICIAL INTELLIGENCE, 2024, 6 (01)
  • [50] Diagnostic and prognostic markers in gliomas - an update
    Ma, R.
    de Pennington, N.
    Hofer, M.
    Blesing, C.
    Stacey, R.
    BRITISH JOURNAL OF NEUROSURGERY, 2013, 27 (03) : 311 - 315
12345